Paper3694715
Carrier-mediated transport of vasopressin across the blood-brain barrier of the mouse.
Banks WA and 3 others. J Neurosci Res, 1987. Cited by 94 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Carrier-mediated transport of vasopressin across the blood-brain barrier of the mouse. Papers, record 3694715. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3694715
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Arginine Vasopressin | Major topic |
| Blood-Brain Barrier | Major topic |
| Carrier Proteins | Major topic |
| Animals | |
| Male | |
| Mice | |
| Mice, Inbred ICR |
Source PubMed
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 94 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,802,863 | Breaching the Blood-Brain Interface: Vasoactive Neurons Contact Capillary Vessels of the Brain Clock in the Suprachiasmatic Nucleus. | eNeuro | 2026 | https://conductscience.org/library/papers/41802863 | PubMed |
| 39,769,071 | Molecular Interaction Between Vasopressin and Insulin in Regulation of Metabolism: Impact on Cardiovascular and Metabolic Diseases. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39769071 | PubMed |
| 38,873,038 | Potential clinical applications of current and future oral forms of desmopressin (Review). | Exp Ther Med | 2024 | https://conductscience.org/library/papers/38873038 | PubMed |
| 37,553,858 | Vasculature of the Suprachiasmatic Nucleus: Pathways for Diffusible Output Signals. | J Biol Rhythms | 2023 | https://conductscience.org/library/papers/37553858 | PubMed |
| 34,561,434 | Identification of the suprachiasmatic nucleus venous portal system in the mammalian brain. | Nat Commun | 2021 | https://conductscience.org/library/papers/34561434 | PubMed |
| 33,999,965 | Minimally invasive brain injections for viral-mediated transgenesis: New tools for behavioral genetics in sticklebacks. | PLoS One | 2021 | https://conductscience.org/library/papers/33999965 | PubMed |
| 30,535,799 | Penetration of the blood-brain barrier by peripheral neuropeptides: new approaches to enhancing transport and endogenous expression. | Cell Tissue Res | 2019 | https://conductscience.org/library/papers/30535799 | PubMed |
| 25,805,003 | Peptides and the blood-brain barrier. | Peptides | 2015 | https://conductscience.org/library/papers/25805003 | PubMed |
| 25,786,864 | Drug transport into the central nervous system: using newer findings about the blood-brain barriers. | Drug Deliv Transl Res | 2012 | https://conductscience.org/library/papers/25786864 | PubMed |
| 25,165,051 | Idiopathic cerebrospinal fluid overproduction: case-based review of the pathophysiological mechanism implied in the cerebrospinal fluid production. | Croat Med J | 2014 | https://conductscience.org/library/papers/25165051 | PubMed |
| 9,710,442 | Human blood-brain barrier receptors for Alzheimer's amyloid-beta 1- 40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer. | J Clin Invest | 1998 | https://conductscience.org/library/papers/9710442 | PubMed |
| 8,584,471 | Cerebrovascular permeability to peptides: manipulations of transport systems at the blood-brain barrier. | Pharm Res | 1995 | https://conductscience.org/library/papers/8584471 | PubMed |
| 8,485,503 | Drug transport across the blood-brain barrier. III. Mechanisms and methods to improve drug delivery to the central nervous system. | Pharm World Sci | 1993 | https://conductscience.org/library/papers/8485503 | PubMed |
| 8,202,551 | Macromolecular permeability across the blood-nerve and blood-brain barriers. | Proc Natl Acad Sci U S A | 1994 | https://conductscience.org/library/papers/8202551 | PubMed |
| 7,870,884 | Bombesin-induced anorexia requires central bombesin receptor activation: independence from interaction with central catecholaminergic systems. | Psychopharmacology (Berl) | 1993 | https://conductscience.org/library/papers/7870884 | PubMed |
| 2,568,658 | Effect of neurotransmitters on the system that transports Tyr-MIF-1 and the enkephalins across the blood-brain barrier: a dominant role for serotonin. | Psychopharmacology (Berl) | 1989 | https://conductscience.org/library/papers/2568658 | PubMed |
| 2,339,105 | Transport of desglycinamide-arginine vasopressin across the blood-brain barrier in rats as evaluated by the unit impulse response methodology. | Pharm Res | 1990 | https://conductscience.org/library/papers/2339105 | PubMed |
| 1,975,697 | Permeability of the murine blood-brain barrier to some octapeptide analogs of somatostatin. | Proc Natl Acad Sci U S A | 1990 | https://conductscience.org/library/papers/1975697 | PubMed |
| 1,798,668 | Delivering peptides to the central nervous system: dilemmas and strategies. | Pharm Res | 1991 | https://conductscience.org/library/papers/1798668 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3694715
GET https://conductscience.org/api/papers/v1/3694715/authors